INMODE LTD (INMD) Fundamental Analysis & Valuation

NASDAQ:INMD • IL0011595993

Current stock price

14.365 USD
-0.04 (-0.24%)
Last:

This INMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. INMD Profitability Analysis

1.1 Basic Checks

  • INMD had positive earnings in the past year.
  • In the past year INMD had a positive cash flow from operations.
  • Each year in the past 5 years INMD has been profitable.
  • Each year in the past 5 years INMD had a positive operating cash flow.
INMD Yearly Net Income VS EBIT VS OCF VS FCFINMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

1.2 Ratios

  • With an excellent Return On Assets value of 12.24%, INMD belongs to the best of the industry, outperforming 92.51% of the companies in the same industry.
  • INMD's Return On Equity of 13.73% is amongst the best of the industry. INMD outperforms 88.24% of its industry peers.
  • INMD's Return On Invested Capital of 10.44% is amongst the best of the industry. INMD outperforms 90.37% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for INMD is significantly above the industry average of 9.12%.
  • The 3 year average ROIC (14.88%) for INMD is well above the current ROIC(10.44%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 12.24%
ROE 13.73%
ROIC 10.44%
ROA(3y)19.41%
ROA(5y)23.56%
ROE(3y)21.54%
ROE(5y)26.69%
ROIC(3y)14.88%
ROIC(5y)21.59%
INMD Yearly ROA, ROE, ROICINMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • The Profit Margin of INMD (25.33%) is better than 95.72% of its industry peers.
  • In the last couple of years the Profit Margin of INMD has declined.
  • The Operating Margin of INMD (23.05%) is better than 95.19% of its industry peers.
  • INMD's Operating Margin has declined in the last couple of years.
  • INMD's Gross Margin of 78.54% is amongst the best of the industry. INMD outperforms 90.37% of its industry peers.
  • In the last couple of years the Gross Margin of INMD has declined.
Industry RankSector Rank
OM 23.05%
PM (TTM) 25.33%
GM 78.54%
OM growth 3Y-19.12%
OM growth 5Y-8.19%
PM growth 3Y-10.69%
PM growth 5Y-6.99%
GM growth 3Y-2.15%
GM growth 5Y-1.58%
INMD Yearly Profit, Operating, Gross MarginsINMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. INMD Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so INMD is still creating some value.
  • Compared to 1 year ago, INMD has less shares outstanding
  • Compared to 5 years ago, INMD has less shares outstanding
  • There is no outstanding debt for INMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INMD Yearly Shares OutstandingINMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
INMD Yearly Total Debt VS Total AssetsINMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • INMD has an Altman-Z score of 10.18. This indicates that INMD is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 10.18, INMD belongs to the best of the industry, outperforming 87.70% of the companies in the same industry.
  • INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.18
ROIC/WACC1.22
WACC8.53%
INMD Yearly LT Debt VS Equity VS FCFINMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 9.88 indicates that INMD has no problem at all paying its short term obligations.
  • The Current ratio of INMD (9.88) is better than 92.51% of its industry peers.
  • A Quick Ratio of 8.83 indicates that INMD has no problem at all paying its short term obligations.
  • INMD has a Quick ratio of 8.83. This is amongst the best in the industry. INMD outperforms 91.98% of its industry peers.
Industry RankSector Rank
Current Ratio 9.88
Quick Ratio 8.83
INMD Yearly Current Assets VS Current LiabilitesINMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. INMD Growth Analysis

3.1 Past

  • The earnings per share for INMD have decreased by -8.99% in the last year.
  • The Earnings Per Share has been growing by 8.96% on average over the past years. This is quite good.
  • The Revenue has decreased by -6.16% in the past year.
  • The Revenue has been growing by 12.45% on average over the past years. This is quite good.
EPS 1Y (TTM)-8.99%
EPS 3Y-12.64%
EPS 5Y8.96%
EPS Q2Q%9.52%
Revenue 1Y (TTM)-6.16%
Revenue growth 3Y-6.57%
Revenue growth 5Y12.45%
Sales Q2Q%6.13%

3.2 Future

  • Based on estimates for the next years, INMD will show a small growth in Earnings Per Share. The EPS will grow by 1.48% on average per year.
  • INMD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.92% yearly.
EPS Next Y-9%
EPS Next 2Y-1.83%
EPS Next 3Y1.48%
EPS Next 5YN/A
Revenue Next Year-0.26%
Revenue Next 2Y1.48%
Revenue Next 3Y1.92%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
INMD Yearly Revenue VS EstimatesINMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
INMD Yearly EPS VS EstimatesINMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

8

4. INMD Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.87, the valuation of INMD can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 93.05% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.42. INMD is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 9.74, the valuation of INMD can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, INMD is valued cheaply inside the industry as 95.19% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of INMD to the average of the S&P500 Index (22.29), we can say INMD is valued rather cheaply.
Industry RankSector Rank
PE 8.87
Fwd PE 9.74
INMD Price Earnings VS Forward Price EarningsINMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, INMD is valued cheaper than 99.47% of the companies in the same industry.
  • INMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INMD is cheaper than 97.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.8
EV/EBITDA 3.18
INMD Per share dataINMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The excellent profitability rating of INMD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.99
EPS Next 2Y-1.83%
EPS Next 3Y1.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INMD Dividend Analysis

5.1 Amount

  • No dividends for INMD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INMD Fundamentals: All Metrics, Ratios and Statistics

INMODE LTD

NASDAQ:INMD (4/27/2026, 2:43:02 PM)

14.365

-0.04 (-0.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners56.56%
Inst Owner Change0.49%
Ins Owners11.36%
Ins Owner Change0%
Market Cap910.17M
Revenue(TTM)370.50M
Net Income(TTM)93.83M
Analysts75.38
Price Target17.34 (20.71%)
Short Float %6.29%
Short Ratio3.15
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.57%
Min EPS beat(2)5.11%
Max EPS beat(2)8.04%
EPS beat(4)3
Avg EPS beat(4)2.52%
Min EPS beat(4)-13.69%
Max EPS beat(4)10.61%
EPS beat(8)4
Avg EPS beat(8)-4.69%
EPS beat(12)7
Avg EPS beat(12)-1.79%
EPS beat(16)11
Avg EPS beat(16)1.34%
Revenue beat(2)1
Avg Revenue beat(2)0.45%
Min Revenue beat(2)-2.48%
Max Revenue beat(2)3.38%
Revenue beat(4)1
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-2.87%
Max Revenue beat(4)3.38%
Revenue beat(8)2
Avg Revenue beat(8)-5.72%
Revenue beat(12)4
Avg Revenue beat(12)-4.28%
Revenue beat(16)8
Avg Revenue beat(16)-2.02%
PT rev (1m)1.19%
PT rev (3m)2.41%
EPS NQ rev (1m)-0.63%
EPS NQ rev (3m)-12.05%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)-12.27%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)-1.38%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-3.48%
Valuation
Industry RankSector Rank
PE 8.87
Fwd PE 9.74
P/S 2.46
P/FCF 10.8
P/OCF 10.68
P/B 1.33
P/tB 1.33
EV/EBITDA 3.18
EPS(TTM)1.62
EY11.28%
EPS(NY)1.47
Fwd EY10.26%
FCF(TTM)1.33
FCFY9.26%
OCF(TTM)1.35
OCFY9.37%
SpS5.85
BVpS10.78
TBVpS10.78
PEG (NY)N/A
PEG (5Y)0.99
Graham Number19.8251 (38.01%)
Profitability
Industry RankSector Rank
ROA 12.24%
ROE 13.73%
ROCE 12.27%
ROIC 10.44%
ROICexc 51.74%
ROICexgc 51.74%
OM 23.05%
PM (TTM) 25.33%
GM 78.54%
FCFM 22.75%
ROA(3y)19.41%
ROA(5y)23.56%
ROE(3y)21.54%
ROE(5y)26.69%
ROIC(3y)14.88%
ROIC(5y)21.59%
ROICexc(3y)140.37%
ROICexc(5y)572.43%
ROICexgc(3y)140.37%
ROICexgc(5y)572.43%
ROCE(3y)17.49%
ROCE(5y)25.39%
ROICexgc growth 3Y-64.14%
ROICexgc growth 5Y-69.81%
ROICexc growth 3Y-64.14%
ROICexc growth 5Y-69.81%
OM growth 3Y-19.12%
OM growth 5Y-8.19%
PM growth 3Y-10.69%
PM growth 5Y-6.99%
GM growth 3Y-2.15%
GM growth 5Y-1.58%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 139.86%
Cap/Sales 0.26%
Interest Coverage 250
Cash Conversion 99.04%
Profit Quality 89.83%
Current Ratio 9.88
Quick Ratio 8.83
Altman-Z 10.18
F-Score4
WACC8.53%
ROIC/WACC1.22
Cap/Depr(3y)114.97%
Cap/Depr(5y)150.7%
Cap/Sales(3y)0.19%
Cap/Sales(5y)0.24%
Profit Quality(3y)83.88%
Profit Quality(5y)93.71%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.99%
EPS 3Y-12.64%
EPS 5Y8.96%
EPS Q2Q%9.52%
EPS Next Y-9%
EPS Next 2Y-1.83%
EPS Next 3Y1.48%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.16%
Revenue growth 3Y-6.57%
Revenue growth 5Y12.45%
Sales Q2Q%6.13%
Revenue Next Year-0.26%
Revenue Next 2Y1.48%
Revenue Next 3Y1.92%
Revenue Next 5YN/A
EBIT growth 1Y-23.82%
EBIT growth 3Y-24.44%
EBIT growth 5Y3.24%
EBIT Next Year-6.87%
EBIT Next 3Y1.31%
EBIT Next 5YN/A
FCF growth 1Y-36.15%
FCF growth 3Y-22.35%
FCF growth 5Y1.38%
OCF growth 1Y-35.73%
OCF growth 3Y-22.28%
OCF growth 5Y1.48%

INMODE LTD / INMD Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INMODE LTD?

ChartMill assigns a fundamental rating of 7 / 10 to INMD.


Can you provide the valuation status for INMODE LTD?

ChartMill assigns a valuation rating of 8 / 10 to INMODE LTD (INMD). This can be considered as Undervalued.


Can you provide the profitability details for INMODE LTD?

INMODE LTD (INMD) has a profitability rating of 8 / 10.


What is the financial health of INMODE LTD (INMD) stock?

The financial health rating of INMODE LTD (INMD) is 10 / 10.